HUELSMANN; PETER MICHAEL

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUELSMANN; PETER MICHAEL.The latest application filed is for "antibody that binds to vegf and il-1beta and methods of use".

Company Profile

7.7.15

HUELSMANN; PETER MICHAEL - PENZBERG DE
HUELSMANN; Peter Michael - Habach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody That Binds To Vegf And Il-1beta And Methods Of Use App 20220041707 - BECKMANN; ROLAND ; et al.	2022-02-10
Antibody that binds to VEGF and IL-1beta and methods of use Grant 11,130,804 - Beckmann , et al. September 28, 2	2021-09-28
Novel Antibody Format App 20210171619 - DENGL; Stefan ; et al.	2021-06-10
Expression Vector Organization, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides App 20210054083 - Huelsmann; Peter Michael ; et al.	2021-02-25
Expression Vector Element Combinations, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides App 20210024952 - Huelsmann; Peter Michael ; et al.	2021-01-28
Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides Grant 10,882,910 - Huelsmann , et al. January 5, 2	2021-01-05
Bispecific antibodies and methods of use in ophthalmology Grant 10,730,938 - Bedoucha , et al.	2020-08-04
Antibody That Binds To Vegf And Il-1beta And Methods Of Use App 20200199214 - BECKMANN; ROLAND ; et al.	2020-06-25
Anti-ANG2 antibodies and methods of use Grant 10,538,585 - Dengl , et al. Ja	2020-01-21
Novel Antibody Format App 20190218282 - DENGL; STEFAN ; et al.	2019-07-18
Anti-IL-1beta antibodies Grant 10,344,085 - Dengl , et al. July 9, 2	2019-07-09
Expression Vector Organization, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides App 20180334505 - HUELSMANN; Peter Michael ; et al.	2018-11-22
Anti-PDGF-B antibodies and methods of use Grant 10,087,246 - Bedoucha , et al. October 2, 2	2018-10-02
Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides Grant 9,963,511 - Huelsmann , et al. May 8, 2	2018-05-08
Anti-ang2 Antibodies And Methods Of Use App 20170247441 - Dengl; Stefan ; et al.	2017-08-31
ANTI-IL-1beta ANTIBODIES AND METHODS OF USE App 20170247447 - Dengl; Stefan ; et al.	2017-08-31
Anti-pdgf-b Antibodies And Methods Of Use App 20170247440 - Bedoucha; Marc ; et al.	2017-08-31
Bispecific Antibodies And Methods Of Use In Ophthalmology App 20170240629 - Bedoucha; Marc ; et al.	2017-08-24
Expression Vector Element Combinations, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides App 20160208284 - Huelsmann; Peter Michael ; et al.	2016-07-21
Method For The Selection And Production Of Tailor-made, Selective And Multi-specific Therapeutic Molecules Comprising At Least Two Different Targeting Entities And Uses Thereof App 20150232560 - HEINDL; DIETER ; et al.	2015-08-20
Full Length Antibody Display System For Eukaryotic Cells And Its Use App 20150038354 - HUELSMANN; PETER MICHAEL ; et al.	2015-02-05
Expression Vector Organization, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides App 20140370547 - Huelsmann; Peter Michael ; et al.	2014-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.